David A. Gass performs domestic and international patent prosecution, with a particular emphasis in biotechnology-related matters. His patent law experience includes interference proceedings before the U.S. Patent and Trademark Office and advising foreign counsel in foreign patent prosecution and opposition proceedings. Mr. Gass also counsels clients concerning all aspects of intellectual property as they relate to business strategies and patent life cycle management, and prepares opinions directed to patent validity, infringement, and freedom to operate. Mr. Gass assists clients with the negotiation and drafting of licenses and other agreements pertaining to patent, trademark, copyright, and other intellectual property rights.
Mr. Gass has handled matters in a wide variety of biotechnology disciplines, such as:
- Recombinant DNA, protein, and antibody technologies
- Genomics and proteomics
- Recombinant growth factors, enzymes, chemokines, and cell surface receptors
- Angiogenesis and anti-angiogenesis technologies and circulatory disorders
- Gene therapy, interfering RNA, and antisense technologies
- Genetic engineering of plants and animals
- Cancer and oncogenes
- Polymerase chain reaction and mass spectrometry
- Nanotechnology and industrial biopolymers
- Transgenic organisms
- Prions, Alzheimer's disease, and neural regeneration
- Inflammation and arthritis
- Therapeutic methodologies and formulations
- Medical diagnostics and kits that involve both traditional and genetic methodologies
- Food and beverage formulations
- Restriction endonuclease reactions
Mr. Gass received his J.D. from Boalt Hall School of Law, University of California-Berkeley. He attended the University of Michigan as an undergraduate, and graduated with Highest Honors and Highest Distinction with a B.S. in Cell and Molecular Biology.
Prior to attending law school, Mr. Gass worked for two years at the University of Michigan as a researcher studying plant mitochondrial genetics.
REPRESENTATIVE MATTERS
Barton v. Fischhoff (Monsanto)* v. Adang (Mycogen Plant Science)
U.S. Patent Office
Case Type: Interference
Area of Practice: Biotechnology
Birkenbach v. Godiska (ICOS Corporation)*
U.S. Patent Office
Case Type: Interference
Area of Practice: Biotechnology
Godiska (ICOS Corporation)* v. Li (Human Genome Sciences)
U.S. Patent Office
Case Type: Interference
Area of Practice: Biotechnology
Opposition on behalf of Ludwig Institute for Cancer Research* re: Genentech Inc.
Australian Patent Office; European Patent Office
Case Type: Opposition
Area of Practice: Biotechnology
Opposition on behalf of Ludwig Institute for Cancer Research* re: Human Genome Sciences Inc.
Australian Patent Office; European Patent Office
Case Type: Opposition
Area of Practice: Biotechnology
Opposition re: Ludwig Institute for Cancer Research* and Licentia Ltd.*
Australian Patent Office and European Patent Office
Case Type: Opposition
Area of Practice: Biotechnology
Opposition re: ICOS Corporation*
European Patent Office
Case Type: Opposition
Area of Practice: Biotechnology
Opposition on behalf of Monsanto* re: Ciba-Geigy
European Patent Office
Case Type: Opposition
Area of Practice: Biotechnology
*Party Represented
